PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
100 hedge funds and large institutions have $82.1M invested in Paratek Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
84% less call options, than puts
Call options by funds: $25K | Put options by funds: $160K
Holders
100
Holding in Top 10
1
Calls
$25K
Puts
$160K
Top Buyers
| 1 | +$3.14M | |
| 2 | +$2.38M | |
| 3 | +$851K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$674K |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$603K |
Top Sellers
| 1 | -$3.37M | |
| 2 | -$435K | |
| 3 | -$406K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$384K |
| 5 |
Two Sigma Advisers
New York
|
-$299K |